Deciphering diseases and biological targets for environmental chemicals using toxicogenomics networks

PLoS Computational Biology

Volumn 6, Issue 5, 2010, Pages 1-11

  Audouze, Karine ^a   Juncker, Agnieszka Sierakowska ^a   Roque, Francisco J S S A ^a   Krysiak Baltyn, Konrad ^a   Weinhold, Nils ^a   Taboureau, Olivier ^a   Jensen, Thomas Skøt ^a   Brunak, Søren ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; HEALTH RISKS; PROTEINS;

BIOLOGICAL TARGETS; COMPUTATIONAL SYSTEM; ENVIRONMENTAL CHEMICALS; HIGH CONFIDENCE; HUMAN HEALTH; HUMAN PROTEINS; MOLECULAR MECHANISM; PROTEIN-PROTEIN ASSOCIATIONS; SYSTEMS BIOLOGY; TOXICOGENOMICS;

CHEMICALS;

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CYTOCHROME P450 3A4; ENVIRONMENTAL CHEMICAL; PERMETHRIN; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PIRINIXIC ACID;

ARTICLE; BINDING AFFINITY; BREAST CANCER; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; GENE EXPRESSION; GENE REGULATORY NETWORK; HUMAN; INTEGRATION; LUNG CANCER; MATHEMATICAL COMPUTING; NECROSIS; PREDICTION; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RISK FACTOR; TOXICOGENETICS;

EID: 77955503019     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1000788     Document Type: Article

References (60)

1. Edwards TM, Myers JP (2008) Environmental exposures and gene regulation in disease etiology. Cien saude Colet 13: 269-281.
2. Phillips DH, Arlt VM (2009) Genotoxicity: damage to DNA and its consequences. EXS 99: 87-110.
3. Paolini GV, Shapland RH, van Hoorn WP, Mason JS, Hopkins AL (2006) Global mapping of pharmacological space. Nat Biotechnol 24: 805-815.
4. Hopkins AL (2007) Network pharmacology. Nat Biotechnol 25: 1110-1111.
5. Yildirim MA, Goh KI, Cusick ME, Barabasi AL, Vidal M (2007) Drug-target network. Nat Biotechno l 25: 1119-1126.
6. Keith CT, Borisy AA, Stockwell BR (2005) Multicomponent therapeutics for networked systems. Nat Rev Drug Discovery 4: 71-78.
7. Morphy R, Rankovic Z (2007) Fragments network biology and designing multiple ligands. Drug Discov Today 12: 156-160.
8. Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, et al. (2007) Relating protein pharmacology by their ligand chemistry. Nat Biotechnol 25: 197-206.
9. Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P (2008) Drug target identification using side-effect similarity. Science 321: 263-266.
10. Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, et al. (2009) Predicting new molecular targets for known drugs. Nature 462: 175-81.
11. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, et al. (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313: 1929-35.
12. Williams-Devane CR, Wolf MA, Richard AM (2009) Toward a public toxicogenomics capability for supporting predictive toxicology: survey of current resources and chemical indexing of experiments in GEO and ArrayExpress. Toxicol Sci 109: 358-71.
13. Yang L, Milutinovic PS, Brosnan RJ, Eger EI, 2nd, Sonner JM (2007) The plasticizers di(2-ethylhexyl) phthalate modulates gamma-aminobutyric acid type A and glycine receptor function. Anesth Analg 105: 393-396.
14. Davis AP, Murphy CG, Saraceni-Richards CA, Rosenstein MC, Wiegers TC, et al. (2009) Comparative Toxicogenomics Database: a knowledgebase and discovery tool for chemical-gene-disease networks. Nucleic Acids Res Database issue: D786-92.
15. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, et al. (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res Database issue: D901-6.
16. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46: 3-26.
17. Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, et al. (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45: 2615-2623.
18. Lage K, Karlberg EO, Størling ZM, Olason PI, Pedersen AG, et al. (2007) A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol 25: 309-316.
19. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, et al. (2005) Towards a proteome-scale map of the human protein-protein interaction network. Nature 437: 1173-8.
20. Ashburner M, et al. (2000) Gene Ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature Genet 25: 25-29.
21. Bader GD, Hogue CW (2003) An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 4: 2.
22. van Dongen S (2000) A cluster algorithm for graphs Technical Report INSR0010. version 1006 National Research Institute for Mathematics and Computer Science in the Netherlands Amsterdam Available from: http:// ww.micans.org/mcl/.
23. Brohée S, van Helden J (2006) Evaluation of clustering algorithms for proteinprotein interaction networks. BMC Bioinformatics 7: 488.
24. Vlasblom J, Wodak SJ (2009) Markov clustering versus affinity propagation for the partitioning of protein interaction graphs. BMC Bioinformatics 10: 99.
25. Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D (1997) GeneCards: integrating information about genes proteins and diseases. Trends in Genetics 13: 163.
26. Salehi F, Turner MC, Phillips KP, Wigle DT, Krewski D, et al. (2008) Review of the etiology of breast cancer with special attention to organochlorines as potential endocrine disruptors. J Toxicol Environ Health B Crit Rev 11: 276-300.
27. Geier DA, Sykes LK, Geier MR (2007) A review of thimerosal (merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness. J Toxicol Env Health 10: 575-596.
28. Westphal GA, Asgari S, Schulz TG, Bünger J, Müller M, et al. (2003) Thimerosal induces micronuclei in the cytochalasin B block micronucleus test with human lymphocytes. Arch Toxicol 77: 50-55.
29. Kuper CF, Stierum RH, Boorsma A, Schijf MA, Prinsen M, et al. (2008) The contact allergen dinitrochlorobenzene (DNCB) and respiratory allergy in the Th2-prone Brown Norway rat. Toxicology 246: 213-221.
30. Sani HA, Rahmat A, Ismail M, Rosli R, Endrini S (2004) Potential anticancer effect of red spinach (Amaranthus gangeticus) extract. Asia Pac J Clin Nutr 13: 396-400.
31. Block G, Patterson B, Subar A (1992) Fruit vegetables and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18: 1-29.
32. Krinsky NI, Johnson EJ (2005) Carotenoid actions and their relation to health and disease. Mol Aspects Med 26: 459-516.
33. Peters U, et al. (1997) Serum lycopene other carotenoids and prostate cancer risk: a nested case-control study in the prostate lung colorectal and ovarian cancer scrrening trial. Cancer Epidemiol Biomarkers Prev 16: 109-126.
34. Toniolo P, Van Kappel AL, Akhmedkhanov A, Ferrari P, Kato I, et al. (2001) Serum carotenoids and breast cancer. Am J Epidemiol 153: 1142-1147.
35. Martinasso G, Maggiora M, Trombetta A, Angela CR, Muzio G (2006) Effetcs of di(2-ethylhexyl) phthalate a widely used peroxisome proliferator and plasticizers on cell growth in the human keratinocyte cell line NCTC 2544. J toxicol Env Health 69: 353-365.
36. Latini G (2000) Potential hazards of exposure to di-2-ethylhexyl phthalate in babies: a review. Biol Neonate 78: 268-276.
37. Turan N, Waring RH, Ramsden DB (2005) The effect of plasticisers on ''sulphate supply'' enzymes. Mol Cell Endocrinol 244: 15-19.
38. Kim HS, Ishizuka M, Kazusaka A, Fujita S (2004) Alterations of activities of cytosolic phospholipase A2 and arachidonic acid metabolizing enzymes in di-(2- ethylhexyl) phthalate induced testicular atrophy. J Vet Med Sci 66: 1119-1124.
39. Horiuchi Y, Nakayama J, Ishiguro H, Ohtsuki T, Detera-Wadleigh SD, et al. (2004) Possible association between a haplotype of the GABA-A receptor alpha 1 subunit gene (GABRA1) and mood disorders. Biol Psychiatry 55: 40-45.
40. Moon BH, et al. (2008) A single administration of 2,3,7,8-tetrachlorodibenzo-pdioxin that produces reduced food and water intake induces long-lasting expression of corticotropin-releasing factor arginine vasopressin and proopiomelanocortin in rat brain. Toxicol Appl Pharmacol 233: 314-322.
41. Legare ME, Hanneman WH, Barhoumi R, Burghardt RC, Tiffany-Castoglioni E (2000) 2,3,7,8-tetrachlorodibenzo-p-dioxin alters hippocampal astroglia-neuronal gap junctional communication. Neurotoxicology 21: 1109-1116.
42. Nayyar T, Zawia NH, Hood DB (2002) Transplacental effects of 2,3,7,8- tetrachlorodibenzo-p-dioxin on the temporal modulation of Sp1 DNA binding in the developing cerebral cortex and cerebellum. Exp Toxicol Pathol 53: 461-468.
43. Kakeyama M, Sone H, Miyabara Y, Tohyama C (2003) Perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin alters activity-dependent expression of BDNF mRNA in the neocortex and male rat sexual behavior in adulthood. Neurotoxicology 24: 207-217.
44. Kim SY, Yang JH (2005) Neurotoxic effects of 2,3,7,8-tetrachlorodibenzo-pdioxin in cerebellar granule cells. Exp Mol Med 37: 58-64.
45. Boverhof DR, Burgoon LD, Tashiro C, Sharratt B, Chittim B, et al. (2006) Comparative toxicogenomics analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice. Toxicol Sci 94: 398-416.
46. Fletcher N, Wahlström D, Lundberg R, Nilsson CB, Nilsson KC, et al. (2005) 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism bile acid biosynthesis and bile transport in rat liver: a microarray study. Toxicol Appl Pharmacol 207: 1-24.
47. Volz DC, Bencic DC, Hinton DE, Law JM, Kullman SW (2005) 2,3,7,8- Tetrachlorodibenzo-p-dioxin (TCDD) induces organ-specific differential gene expression in male Japanese medaka (Oryzias latipes). Toxicol Sci 85: 572-84.
48. Lalwani ND, Reddy MK, Qureshi SA, Reddy JK (1981) Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(23-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14643) in the semipurified diet. Carcinogenesis 2: 645-650.
49. Suga T (2004) Hepatocarcinogenesis by peroxisome proliferators. J Toxicol Sci 29: 1-12.
50. Amacher DE, Adler R, Herath A, Townsend RR (2005) Use of proteomic methods to identify serum biomarkers associated with rat liver toxicity or hypertrophy. Clin Chem 51: 1796-1803.
51. Bauer D, Wolfram N, Kahl GF, Hirsh-Ernst KI (2004) Transcriptional regulation of CYP2B1 induction in primary rat hepatocyte cultures: repression by epidermal growth chemical is mediated via a distal enhancer region. Mol Pharmaco 65: 172-180.
52. Heder AF, Hirsch-Ernst KI, Bauer D, Kahl GF, Desel H (2001) Induction of cytochrome P450 2B1 by pyrethroids in primary rat hepatocyte cultures. Biochem Pharmacol 62: 71-79.
53. Eil C, Nisula BC (1990) The binding properties of pyrethroids to human skin fibroblast androgen receptors and to sex hormone binding globulin. J Steroid Biochem 35: 409-414.
54. von Mering C, Jensen LJ, Kuhn M, Chaffron S, Doerks T, et al. (2007) STRING 7- recent developments in the integration and prediction of protein interactions. Nucleic Acids Res 35: 358-362.
55. Stein LD (2004) Human Genome: End of the Beginning. Nature 431: 915-916.
56. Oprea TI, Tropsha A (2006) Target chemical and bioactivity databases -integration is key. Drug Discov today technol 3: 357-365.
57. Mestres J, Gregori-Puigjané E, Valverde S, Solé RV (2008) Data completeness- -the Achilles heel of drug-target networks. Nat Biotechnol 26: 983-984.
58. Birney E, Andrews TD, Bevan P, Caccamo M, Chen Y, et al. (2004) An Overview of Ensembl. Genome Res 145: 925-928.
59. Online Mendelian Inheritance in Man, OMIM (TM). McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim/.
60. Bonferroni CE (1935) Il calcolo delle assicurazioni su gruppi di teste In Studi in Onore del Professore Salvatore Ortu Carboni Rome:. pp Italy13-60.